CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
16-30 of 1187
Komal Jhaveri, MD, FACP
Virginia Kaklamani, MD, DSc
The Sequencing Puzzle: Integrating Oral SERDs and PROTACs into the mBC Treatment Landscape
MinuteCE®The Sequencing Puzzle: Integrating Oral SERDs and PROTACs into the mBC Treatment Landscape
Komal Jhaveri, MD, FACP
Virginia Kaklamani, MD, DSc
Secondary Stroke Prevention: Antithrombotic Strategies for Neurologists, Hematologists, and Cardiologists
CME/CESecondary Stroke Prevention: Antithrombotic Strategies for Neurologists, Hematologists, and Cardiologists
Deborah Siegal, MD, MSc, FRCPC
Geoffrey Barnes, MD, MSc
Mike Sharma, MD, MSc, FRCPC
Jeffrey Weitz, MD
Bridging the Bronchiectasis Gap: The Latest Emerging Multimodal Treatment Approaches
CME/CEBridging the Bronchiectasis Gap: The Latest Emerging Multimodal Treatment Approaches
Ashley Losier, MD
Ari Ciment, MD
Laura Brenner, MD
Oral GLP-1 RA Therapy in Type 2 Diabetes and High Cardiovascular Risk
CME/CEOral GLP-1 RA Therapy in Type 2 Diabetes and High Cardiovascular Risk
Brian P. McDonough, MD, FAAFP
Silvio Inzucchi, MD
Jay H. Shubrook, DO, FACOFP, FAAFP
Engaging Patients With Heart Failure and Chronic Hyperkalemia: Shared Decision-Making to Support Guideline-Directed Medical Therapy
CME/CEEngaging Patients With Heart Failure and Chronic Hyperkalemia: Shared Decision-Making to Support Guideline-Directed Medical Therapy
Gianluigi Savarese, MD, PhD, FESC, FHFA
- advertisement
Patient Portal: Leveraging Technology to Improve Safety with Clinical Decision-Making for People with Diabetes
CME/CEPatient Portal: Leveraging Technology to Improve Safety with Clinical Decision-Making for People with Diabetes
Ketan Dhatariya, MBBS, MSc, MD, MS, FRCP, PhD
Eden Miller, DO, D-ACD, D-ABOM
A New Lens on DKA: Leveraging the Latest Tech for Improved Patient Outcomes
CME/CEA New Lens on DKA: Leveraging the Latest Tech for Improved Patient Outcomes
Jennifer Goldman, PharmD, CDCES, BC-ADM-FCCP
Ketan Dhatariya, MBBS, MSc, MD, MS, FRCP, PhD
CELMoDs in Multiple Myeloma: Optimizing RRMM Treatment With Potent Immunomodulatory Drugs
CME/CECELMoDs in Multiple Myeloma: Optimizing RRMM Treatment With Potent Immunomodulatory Drugs
Sagar Lonial, MD, FACP
Treating Outside the Box: New Pathways to Retinal Vascular Stability
CME/CE Broadcast ReplayTreating Outside the Box: New Pathways to Retinal Vascular Stability
Rishi Singh, MD, FASRS
Ferhina S. Ali, MD, MPH, FASRS
Baruch D. Kuppermann, MD, PhD
Clinical Evidence for Anti-CD38–Based Frontline Regimens in Transplant-Ineligible Patients With Multiple Myeloma
MinuteCE®Clinical Evidence for Anti-CD38–Based Frontline Regimens in Transplant-Ineligible Patients With Multiple Myeloma
Saad Z. Usmani, MD, MBA
Saad Z. Usmani, MD, MBA
Natalie S. Callander, MD
- advertisement
Case Consult: Implementing Anti-CD38–Based Frontline Regimens in Transplant-Eligible Patients
MinuteCE®Case Consult: Implementing Anti-CD38–Based Frontline Regimens in Transplant-Eligible Patients
Saad Z. Usmani, MD, MBA
Natalie S. Callander, MD
Case Consult: Implementing Anti-CD38–Based Frontline Regimens in Transplant-Ineligible Patients
MinuteCE®Case Consult: Implementing Anti-CD38–Based Frontline Regimens in Transplant-Ineligible Patients
Saad Z. Usmani, MD, MBA
Natalie S. Callander, MD
Addressing the Burden of PH-ILD: Early Recognition, Evidence-Based Management, and Care Coordination
CME/CEAddressing the Burden of PH-ILD: Early Recognition, Evidence-Based Management, and Care Coordination
Steven D. Nathan, MD
Sandeep Sahay, MD, FCCP
